Publicaciones (44) Publicaciones de ESTIBALIZ CAPETILLO GONZÁLEZ DE ZÁRATE

2024

  1. A nonlinear meccano for Alzheimer's emergence by amyloid β-mediated glutamatergic hyperactivity

    Neurobiology of Disease, Vol. 194

2023

  1. Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy

    Autophagy, Vol. 19, Núm. 7, pp. 1952-1981

  2. Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies

    Autophagy, Vol. 19, Núm. 2, pp. 660-677

2022

  1. A Neuron, Microglia, and Astrocyte Triple Co-culture Model to Study Alzheimer’s Disease

    Frontiers in Aging Neuroscience, Vol. 14

  2. Amyloid β / PKC-dependent alterations in NMDA receptor composition are detected in early stages of Alzheimer´s disease

    Cell Death and Disease, Vol. 13, Núm. 3

  3. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

  4. Linking Plasma Amyloid Beta and Neurofilament Light Chain to Intracortical Myelin Content in Cognitively Normal Older Adults

    Frontiers in Aging Neuroscience, Vol. 14

  5. Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  6. New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer's Disease

    International journal of molecular sciences, Vol. 23, Núm. 16

  7. Recombinant Integrin β1 Signal Peptide Blocks Gliosis Induced by Aβ Oligomers

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

2021

  1. Effects of platelet-rich plasma on cellular populations of the central nervous system: The influence of donor age

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-20

  2. Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease

    Theranostics, Vol. 11, Núm. 13, pp. 6542-6559

  3. Polyphenols attenuate mitochondrial dysfunction induced by amyloid peptides

    Mitochondrial Physiology and Vegetal Molecules: Therapeutic Potential of Natural Compounds on Mitochondrial Health (Elsevier), pp. 317-337

  4. Whole blood expression pattern of inflammation and redox genes in mild alzheimer’s disease

    Journal of Inflammation Research, Vol. 14, pp. 6085-6102

2020

  1. Diálogo "Volver a una universidad española": [Entrevista]

    Más talento para la universidad española: retenerlo, atraerlo, recuperarlo (Servei de Comunicació i Publicacions), pp. 209-222

2019

  1. APP depletion alters selective pre- and post-synaptic proteins

    Molecular and Cellular Neuroscience, Vol. 95, pp. 86-95

  2. Corrigendum to "Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease"

    Mediators of inflammation

2018

  1. Contribution of neurons and glial cells to complement-mediated synapse removal during development, aging and in Alzheimer's disease

    Mediators of Inflammation, Vol. 2018

  2. Mangiferin and morin attenuate oxidative stress, mitochondrial dysfunction, and neurocytotoxicity, induced by Amyloid Beta Oligomers

    Oxidative Medicine and Cellular Longevity, Vol. 2018

  3. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis

    EMBO Molecular Medicine, Vol. 10, Núm. 8